Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.59 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.59 |
| ▸ | RECQL | P46063 | 2/20 | 0.59 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.59 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.59 |
| ▸ | F3 | P13726 | 2/20 | 0.59 |
| ▸ | TNKS | O95271 | 1/20 | 0.59 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.59 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.59 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.59 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15950322 | 1.00 | MAPT (0.59) | MAPTLMNAALDH1A1HDAC3HDAC4 | |
| SCHEMBL869265 | 0.91 | MAPT (0.64) | MAPTLMNAALDH1A1HDAC3HDAC4 | |
| SCHEMBL869266 | 0.91 | MAPT (0.64) | MAPTLMNAALDH1A1HDAC3HDAC4 | |
| SCHEMBL320925 | 0.84 | TDP1 (0.57) | MAPTLMNAALDH1A1HDAC3HDAC4 | |
| SCHEMBL320924 | 0.84 | TDP1 (0.57) | MAPTLMNAALDH1A1HDAC3HDAC4 | |
| SCHEMBL29198288 | 0.83 | MAPT (0.59) | MAPTLMNAALDH1A1HDAC3HDAC4 | |
| SCHEMBL9247555 | 0.83 | MAPT (0.64) | MAPTLMNAALDH1A1HDAC3HDAC4 | |
| SCHEMBL21803794 | 0.83 | MAPT (0.64) | MAPTLMNAALDH1A1HDAC3HDAC4 | |
| SCHEMBL775716 | 0.83 | MAPT (0.64) | MAPTLMNAALDH1A1HDAC3HDAC4 | |
| SCHEMBL908549 | 0.82 | MAPT (0.53) | MAPTLMNAALDH1A1HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113873769-B | Method for avoiding solder mask printing ink from being applied to bonding pad | 广东喜珍电路科技有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-113873769-A | Method for avoiding solder mask ink from bonding pad | 奥士康精密电路（惠州）有限公司 | 2021-12-31 | — | — | CN | claimed |
| CN-113873769-B | Method for avoiding solder mask printing ink from being applied to bonding pad | 广东喜珍电路科技有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-113873769-A | Method for avoiding solder mask ink from bonding pad | 奥士康精密电路（惠州）有限公司 | 2021-12-31 | — | — | CN | disclosed |
| EP-1348696-B1 | Use of optically active clausenamides for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same | INST MATERIA MEDICA CAMS (CN) | 2012-02-01 | — | — | EP | disclosed |
| CN-1250546-C | Tetrahydropyrido compound | ALTANA PHARMA (DE) | 2006-04-12 | — | — | CN | disclosed |
| US-6787564-B2 | FOR TREATING HYPOXIA PROTECTIVE, NOOTROPIC AND NEURODEGENERATIVE DISEASES (CERBRAL ISCHEMIA, ALZHEIMER'S DISEASE, AND VASCULAR DEMENTIA) | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2004-09-07 | — | — | US | disclosed |
| CN-1508136-A | Tetrahydropyrido compound | ��̹��ҽҩ��˾ | 2004-06-30 | — | — | CN | disclosed |
| US-20030207935-A1 | Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES | 2003-11-06 | — | — | US | disclosed |
| EP-1348696-A1 | Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2003-10-01 | — | — | EP | disclosed |
| CN-1251102-A | Tetrahydropyrido compounds | BYK GULDEN LOMBERG CHEM FAB (DE) | 2000-04-19 | — | — | CN | disclosed |
| US-4920038-A | Printed circuit manufacture employing a radiation cross-linkable photo-polymer system | SIEMENS AKTIENGESELLSCHAFT | 1990-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207935-A1 | Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | HIF1AN, HIF1A, CLN6 | MAPT 59/4885LMNA 511/4885ALDH1A1 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.